Incidence rate and risk factors for hypoglycemia among individuals with type 1 diabetes or type 2 diabetes in China receiving insulin treatment
Authors' conclusion
These real-world data collected from Chinese patients with diabetes receiving insulin treatment reveal a relatively high percentage of patients experiencing hypoglycemia, with around one quarter of these events classified as severe and as many as 92.5% occurring outside of a hospital or clinic.
Study context
- Population
- Adults with T1D or T2D in China registered on Lilly Connected Care Program (LCCP) 1 February 2019–31 January 2022, using insulin for a full 12-week period after registration
- Participants
- 22,752 adults
- Exposure
- T1DM vs T2DM
- Outcome
- Incidence of level 1 and level 2 hypoglycemia
- Follow-up
- 12 weeks following registration
Methodological detailsreal-world, electronic data collection via Lilly Connected Care Program
- Real-world
- Electronic data collection via Lilly Connected Care Program
Main finding
As reported in the abstract
Level 1 hypoglycemia (patients with monitoring data) · 12 weeks
Observational data: associations, not effects.
Further findings
Level 2 hypoglycemia (patients with monitoring data) · 12 weeks
Treated with OADs capable of producing hypoglycemia (SU or glinide)
- Level 2 hypoglycemia (patients with monitoring data): co-primary outcome with level 1 hypoglycemia
Setting and severity of hypoglycemic events (questionnaire data)
- Hypoglycemic events occurring outside of hospital
- up to 92.5%
- Hypoglycemic events that were serious
- 18.6%
Original publication
Incidence rate and risk factors for hypoglycemia among individuals with type 1 diabetes or type 2 diabetes in China receiving insulin treatment. Diabetes Res Clin Pract. Published 3 November 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →